Cardiac Pacemaker Market, by Product Type (Single-chamber Pacemaker, Dual-chamber Pacemaker, and Biventricular Pacemaker), by Implantability (Implantable Pacemakers and External Pacemakers), by Distribution Channel (Hospitals, Cardiac Clinics, and Ambulat

Cardiac Pacemaker Market, by Product Type (Single-chamber Pacemaker, Dual-chamber Pacemaker, and Biventricular Pacemaker), by Implantability (Implantable Pacemakers and External Pacemakers), by Distribution Channel (Hospitals, Cardiac Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

A cardiac pacemaker is a small device that is implanted in the chest to help control the heartbeats. It is used for the treatment of slow heart beating. Implanting cardiac pacemaker in the chest requires a surgical procedure. There are various types of cardiac pacemaker such as single chamber pacemaker and dual-chamber pacemakers where single chamber pacemaker is used as one lead placed within the lower chamber, or ventricle, of the heart. Cardiac pacemakers are used to treat bradycardia and atrial fibrillation associated with bradycardia. Bradycardia is an abnormally slow heartbeat defined by 60 or less beats per minute. Dual-chamber pacemakers have two leads, placed in the right atrium and right ventricle. They act synchronously when a slow natural heart rate is detected to mimic the sequential physiological contraction of the atria and ventricles. There are two ways followed for implanting pacemakers such as implantable pacemaker and external pacemakers, where in implantable pacemaker, which is a device that implanted (internally) within the body for providing electrical impulses to regulate the heart rhythm or to reproduce that rhythm. External pacemakers is implanted outside the body, which is electrodes based medical device used for maintaining heart rate.
Market Dynamics
Increasing product approvals by regulatory authorities for cardiac pacemaker is expected to drive the global cardiac pacemaker market over the forecast period. For instance, on April 4, 2022, Abbott, a medical device manufacturer announced that the U.S. Food and Drug Administration (FDA) s approved the Aveir single-chamber (VR) leadless pacemaker for the treatment of patients with sluggish cardiac rhythms. Moreover, to treat slower-than-normal heart rates, Aveir leadless pacemaker is placed directly inside the right ventricle of the heart via a minimally invasive surgery. The gadget has a unique mapping function that allows doctors to analyze electrical signals within the heart and identify the device's proper placement before it is implanted.
Key features of the study:
This report provides an in-depth analysis of the global cardiac pacemaker market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cardiac pacemaker market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
Key companies covered as a part of this study include Medtronic, Boston Scientific Corporation, Abbott, BIOTRONIK SE & Co. KG, Pacetronix , Lepu Medical Technology(Beijing)Co., Ltd. , LIVANOVA PLC, MEDICO S.R.L., OSCOR Inc., MicroPort Scientific Corporation, OSYPKA MEDICAL, and Vitatron Holding B.V.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cardiac pacemaker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global cardiac pacemaker market
Detailed Segmentation:
Global Cardiac Pacemaker Market, by Product Type:
Single-chamber Pacemaker
Dual-chamber Pacemaker
Biventricular Pacemaker
Global Cardiac Pacemaker Market, by Implantability:
Implantable Pacemakers
External Pacemakers
Global Cardiac Pacemaker Market, by End User:
Hospitals
Cardiac Clinics
Ambulatory Surgical Centers
Global Cardiac Pacemaker Market, By Region:
North America
By Product Type:
Single-chamber Pacemaker
Dual-chamber Pacemaker
Biventricular Pacemaker
By Implantability:
Implantable Pacemakers
External Pacemakers
By End User:
Hospitals
Cardiac Clinics
Ambulatory Surgical Centers
By Country:
U.S.
Canada
Latin America
By Product Type:
Single-chamber Pacemaker
Dual-chamber Pacemaker
Biventricular Pacemaker
By Implantability:
Implantable Pacemakers
External Pacemakers
By End User:
Hospitals
Cardiac Clinics
Ambulatory Surgical Centers
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Single-chamber Pacemaker
Dual-chamber Pacemaker
Biventricular Pacemaker
By Implantability:
Implantable Pacemakers
External Pacemakers
By End User:
Hospitals
Cardiac Clinics
Ambulatory Surgical Centers
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Product Type:
Single-chamber Pacemaker
Dual-chamber Pacemaker
Biventricular Pacemaker
By Implantability:
Implantable Pacemakers
External Pacemakers
By End User:
Hospitals
Cardiac Clinics
Ambulatory Surgical Centers
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
Middle East
By Product Type:
Single-chamber Pacemaker
Dual-chamber Pacemaker
Biventricular Pacemaker
By Implantability:
Implantable Pacemakers
External Pacemakers
By End User:
Hospitals
Cardiac Clinics
Ambulatory Surgical Centers
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Single-chamber Pacemaker
Dual-chamber Pacemaker
Biventricular Pacemaker
By Implantability:
Implantable Pacemakers
External Pacemakers
By End User:
Hospitals
Cardiac Clinics
Ambulatory Surgical Centers
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Medtronic *
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Boston Scientific Corporation
Abbott
BIOTRONIK SE & Co. KG
Pacetronix
Lepu Medical Technology (Beijing) Co., Ltd.
LIVANOVA PLC
MEDICO S.R.L.
OSCOR Inc.
MicroPort Scientific Corporation,
OSYPKA MEDICAL
Vitatron Holding B.V.
“*” marked represents similar segmentation in other categories in the respective section.